FindTrial
Sign In

Role of Vitamin D in children with Attention Deficit Hyperactivity Disorder

Effect of Vitamin D supplementation on behavioural and executive functions of children with Attention Deficit Hyperactivity Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048799
Enrollment
50
Registered
2023-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F90- Attention-deficit hyperactivity disorders

Interventions

Intervention1: Vitamin D: Effect on Behavioural and executive functions in children with ADHD on follow up of 3 months using VADPRS,Single letter cancellation test, Trail A trail B, Abberant behaviour

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of ADHD as per DSM 5 2. Children between 6- 12 years 3. any gender 4. children with insufficient levels of vitamin D ( >5ng/ml and 5. drug naive patients/ not on ADHD medications for 3 months 6. parents not enrolled in psychoeducation group

Exclusion criteria

Exclusion criteria: 1. Children with history of other comorbid neurodevelopment disorder, specific learning disorders and any other psychiatric comorbidity like oppositional defiant disorder, intellectual disability, autism spectrum disorder, drug abuse, psychotic disorder, mood disorders 2. Children with history of head trauma, encephalitis, meningitis in the past 12 months, neurological diseases like epilepsy, stroke, encephalopathy 3. Children with any chronic medical conditions such as severe malnourishment, diabetes mellitus, or on medications for the same. 4. Children with severe Vitamin D deficiency ( 5. History of toxicity with vitamin D ( >100ng/ml) 6. Use of Vitamin D in the past 3 months

Design outcomes

Primary

MeasureTime frame
Behavioural functions, Executive Functions. Response to treatment will be defined as a 25 percent improvement on symptoms on standard scalesTimepoint: time point will be 3 months Investigator will use scales like VADPRS, Aberrant behaviour checklist, Trail A , trail B , Single letter cancellation test—

Secondary

MeasureTime frame
correlation of ADHD with sociodemographic profile, daily intake of dairy products, daily exposure of sunlightTimepoint: time points will be 3 months—

Countries

India

Contacts

Public ContactDrAarzoo

Government Medical College and hospital, Chnadigarh

drpritiarun@gmail.com9646121612

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026